Furoxan analogues of the histamine H 3-receptor antagonist imoproxifan and related furazan derivatives

Constrained analogues of imoproxifan containing furazan ( n = 0) and furoxan ( n = 1) systems were synthesised and evaluated in vitro as H 3-antagonists. Synthesis and pharmacological characterisation of a series of compounds in which the oxime substructure present in imoproxifan was constrained in...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry Vol. 13; no. 15; pp. 4750 - 4759
Main Authors Tosco, Paolo, Bertinaria, Massimo, Stilo, Antonella Di, Cena, Clara, Sorba, Giovanni, Fruttero, Roberta, Gasco, Alberto
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.08.2005
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Constrained analogues of imoproxifan containing furazan ( n = 0) and furoxan ( n = 1) systems were synthesised and evaluated in vitro as H 3-antagonists. Synthesis and pharmacological characterisation of a series of compounds in which the oxime substructure present in imoproxifan was constrained in the pentatomic NO-donor furoxan ring, as well as their structurally related furazan analogues devoid of NO-donating properties, are described. The whole series of products displayed reversible histamine H 3-antagonistic activity on guinea-pig ileum. 4-(4-(3-(1 H-Imidazol-4-yl)propoxy)phenyl)furoxan-3-carbonitrile 16 was also able to induce partial relaxation when added to the bath after electrical contraction of the guinea-pig ileum during the study of its H 3-antagonistic properties. This phenomenon seems to be dependent on NO-mediated sGC activation. The lipophilic–hydrophilic balance of all the products was investigated.
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2005.05.004